hims & hers Posts Breakout Growth, Raises Revenue Guidance

ED and hair loss startup turned multi-specialty telehealth platform, hims & hers outpaced expectations in its Q1 results.

Hims&Hers: Disrupting the $4T Healthcare Market

Hims & Hers Health: Double-Edged Sword (NYSE:HIMS)

Hims & Hers Health, Inc. Names Khobi Brooklyn as Chief

2022 Year in Review: 13 trends that shaped the Healthcare Landscape

EX-99.2

Subscription-based care moves beyond peddling birth control and

SEC Filing Cue Health Inc.

Hims & Hers caps off impressive 2022 by nearly doubling its

Kry revenue, valuation & growth rate

Hims & Hers charts strong revenue growth, rolls out AI service

EX-99.2

How Hims Built an Online Prescription Drug Empire on Outdated

Is Hims & Hers Health Stock a Buy Now?

Hims & Hers' boost in revenues and users underscores the rise of